Brian Mueller - 14 Mar 2025 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
14 Mar 2025
Transactions value $
-$1,284,432
Form type
4
Filing time
18 Mar 2025, 18:19:33 UTC
Previous filing
27 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Tax liability -$1.28M -18.5K -18.2% $69.44 83.1K 14 Mar 2025 Direct
transaction BMRN Common Stock Award $0 +16.6K +20.01% $0.00 99.8K 17 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Award $0 +38.6K $0.00 38.6K 17 Mar 2025 Common Stock 38.6K $71.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted March 17, 2025. Price not applicable.
F2 Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.